Pierre Savi

8.1k total citations · 1 hit paper
90 papers, 6.1k citations indexed

About

Pierre Savi is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology. According to data from OpenAlex, Pierre Savi has authored 90 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 33 papers in Hematology and 19 papers in Molecular Biology. Recurrent topics in Pierre Savi's work include Antiplatelet Therapy and Cardiovascular Diseases (39 papers), Platelet Disorders and Treatments (25 papers) and Adenosine and Purinergic Signaling (17 papers). Pierre Savi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (39 papers), Platelet Disorders and Treatments (25 papers) and Adenosine and Purinergic Signaling (17 papers). Pierre Savi collaborates with scholars based in France, Belgium and United States. Pierre Savi's co-authors include Jean‐Marc Herbert, Jean‐Pierre Maffrand, Jean‐Marie Pereillo, Françoise Bono, Jean Combalbert, Marc Pascal, C. Picard, Jean‐Marc Herbert, Marie-Claude Laplace and A. Bernat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Pierre Savi

90 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Biological Activity of the Active Metabolite of Clopidogrel

2000 562 citations Pierre Savi, Jean‐Marie Pereillo et al. profile →

Peers

Countries citing papers authored by Pierre Savi

Since Specialization

Citations

This map shows the geographic impact of Pierre Savi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Savi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Savi more than expected).

Fields of papers citing papers by Pierre Savi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Savi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Savi. The network helps show where Pierre Savi may publish in the future.

Co-authorship network of co-authors of Pierre Savi

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Savi. A scholar is included among the top collaborators of Pierre Savi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Savi. Pierre Savi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulator of G-Protein Signaling 18 Controls Both Platelet Generation and Function 2014 ·PLoS ONE ·Nathalie Delesque-Touchard, Caroline Pendaries, (unknown), L. Millet, (unknown), Caroline Hervé, (unknown), (unknown), Catherine Prades, Tania Sorg, Jean‐Marc Herbert, Pierre Savi, Françoise Bono	24
2	SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities 2012 ·Molecular Cancer Therapeutics ·Antoine Alam, Isabelle Blanc, (unknown), Olivier Duclos, Jacques Bonnin, Pauline Barron, Marie-Claude Laplace, (unknown), (unknown), Frédérique Dol, Jean-Pascal Hérault, Paul Schaeffer, Pierre Savi, Françoise Bono	71
3	TNF-alpha induced PMN apoptosis in whole human blood: Protective effect of SSR180575, a potent and selective peripheral benzodiazepine ligand 2010 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Pierre Savi, Françoise Bono	11
4	The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts 2006 ·Proceedings of the National Academy of Sciences ·Pierre Savi, Jean‐Luc Zachayus, Nathalie Delesque-Touchard, (unknown), Caroline Hervé, (unknown), Jean‐Marie Pereillo, Jean‐Michel Culouscou, Françoise Bono, Pascual Ferrara, Jean‐Marc Herbert	238
5	Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy 2005 ·Journal of Clinical Investigation ·Anne Angelillo‐Scherrer, Laurent Burnier, (unknown), Pierre Savi, Maria DeMol, Paul Schaeffer, Jean-Marc Herbert, Greg Lemke, Stephen P. Goff, Glenn K. Matsushima, H. Shelton Earp, Christian Vesin, Marc Hoylaerts, Stéphane Plaisance, Désiré Collen, Edward M. Conway, Bernhard Wehrle‐Haller, Peter Carmeliet	200
6	Gi‐dependent and ‐independent mechanisms downstream of the P2Y12 ADP‐receptor 2004 ·Journal of Thrombosis and Haemostasis ·(unknown), Vincent Sauzeau, Monique Plantavid, Jean‐Marc Herbert, Pierre Pacaud, Bernard Payrastre, Pierre Savi	48
7	Pharmacological Characterization of the Human P2Y13 Receptor 2003 ·Molecular Pharmacology ·Frédéric Marteau, Emmanuel Le Poul, David Communi, Didier Communi, (unknown), Pierre Savi, Jean‐Marie Boeynaems, Nathalie Suarez Gonzalez	184
8	Structure and Stereochemistry of the Active Metabolite of Clopidogrel 2002 ·Drug Metabolism and Disposition ·Jean‐Marie Pereillo, Mohamed Maftouh, (unknown), (unknown), Olivier Fedeli, Pierre Savi, Marc Pascal, Jean‐Marc Herbert, Jean‐Pierre Maffrand, C. Picard	356
9	Interspecies Comparison of the Antiplatelet, Antithrombotic, and Hemorrhagic Effects of SR 121566A, a Novel Nonpeptide GP IIb/IIIa Antagonist 1999 ·Journal of Cardiovascular Pharmacology ·A. Bernat, Peter Hoffmann, Pierre Savi, (unknown), Jean‐Marc Herbert	8
10	Role of P2Y1 purinoceptor in ADP‐induced platelet activation 1998 ·FEBS Letters ·Pierre Savi, Philippe Beauverger, (unknown), (unknown), (unknown), Mourad Kaghad, Jean‐Marc Herbert	154
11	Antiplatelet and Antithrombotic Efficacy of SR 121787, a Nonpeptide Orally Active GP IIb/IIIa Antagonist, in Rabbits: Comparison with Clopidogrel and Aspirin 1997 ·Journal of Cardiovascular Pharmacology ·Peter Hoffmann, A. Bernat, Pierre Savi, J. M. Herbert	17
12	Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide 1997 ·Journal of Cellular Physiology ·Jean‐Marc Herbert, Alexandre Guy, Isabelle Lamarche, Anne-Marie Marés, Pierre Savi, F. Dol	16
13	cAMP is not an important messenger for ADP-induced platelet aggregation 1996 ·Blood Coagulation & Fibrinolysis ·Pierre Savi, (unknown), J. M. Herbert	46
14	Purification and characterization of a novel protease from culture filtrates of aStreptomycessp. 1996 ·FEMS Microbiology Letters ·(unknown), Pierre Savi, (unknown), Mohamed Maftouh, Jean‐Marie Pereillo, Joël Capdevielle, Jean‐Claude Guillemot, J.P. Maffrand, Jean-Marc Herbert	9
15	Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Pierre Savi, Marie-Claude Laplace, J.P. Maffrand, Jean‐Marc Herbert	95
16	Evidence for the existence of two different ADP-binding sites on rat platelets 1994 ·Thrombosis Research ·Pierre Savi, Marie-Claude Laplace, J. M. Herbert	35
17	Characterization of specific binding sites for [3H]2-MeS-ADP on megakaryocytoblastic cell lines in culture 1994 ·Biochemical Pharmacology ·Pierre Savi, Armelle A. Troussard, (unknown)	8
18	Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes 1994 ·Biochemical Pharmacology ·Jean‐Marc Herbert, Pierre Savi, (unknown), Marie-Claude Laplace, (unknown), Jean‐Marie Pereillo, Xavier Emonds‐Alt	14
19	IL‐4 inhibits LPS‐, IL‐1β‐ and TNFα‐induced expression of tissue factor in endothelial cells and monocytes 1992 ·FEBS Letters ·Jean‐Marc Herbert, Pierre Savi, Marie-Claude Laplace, (unknown)	73
20	Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel 1992 ·Biochemical Pharmacology ·Pierre Savi, Jean‐Marc Herbert, (unknown), F. Dol, Denis Delebassée, Jean Combalbert, G. Defreyn, Jean‐Pierre Maffrand	161

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact